Premium
Percutaneous closure of atrial septal defect type ostium secundum using the new Intrasept occluder: Initial experience
Author(s) -
Goy J.J.,
Stauffer J.C.,
Yusoff Z.,
Wong A.R.,
Owlya R.,
Perret F.,
Siegenthaler M.,
Savcic M.,
Ménétrey R.,
Seydoux C.
Publication year - 2006
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.20607
Subject(s) - medicine , percutaneous , shunt (medical) , surgery , ostium , foramen secundum , embolization , thrombus , septum secundum , patent foramen ovale
We report the first experience obtained with the new Intrasept device. We attempted to treat 35 patients with a mean age of 43 ± 21 years. The mean size of the defect was 17/15 mm. It was successfully closed in 31 patients. In the remaining four the device could not be stabilized because of excessive defect size. A small residual shunt was present immediately following implantation in three patients. No complications occurred during the procedure and at 6 months, 31 patients had an uneventful outcome. Only one patient had a small residual shunt. No thrombus, embolization, or device fracture was documented during a mean follow‐up of 17 ± 11 months. Percutaneous closure of ASD ostium secundum is feasible with the Intrasept device with a high success rate and very good medium‐term outcome. Our initial experience and results were excellent with small to medium size defects, however, large defects (>20 mm) remain challenging. © 2006 Wiley‐Liss, Inc.